Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Cigna / Tagrisso Osimertinib Tablets Astrazeneca

Tagrisso Osimertinib Tablets Astrazeneca — Cigna

3 indications indexed for this drug.

Non Small Cell Lung Cancer Advanced Or Metastatic Disease
View coverage criteria
Non Small Cell Lung Cancer Post Tumor Resection Adjuvant The
View coverage criteria
Non Small Cell Lung Cancer Unresectable Stage Iii
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.